April 17, 2014

Posts tagged as: FDA back to homepage

FDA Moves to Eliminate Medical Foods FDA Moves to Eliminate Medical Foods

There’s still a small window to make the FDA listen to reason. “Medical foods,” by the federal government’s definition, aren’t simply a diet plan prescribed by a doctor. They are foods that are specifically formulated and processed for a sick patient and are intended to meet specific nutritional requirements for the management of a disease or condition.

The FDA has recently issued an updated draft guidance that drastically limits the number of conditions that medical foods can be used to manage. Under the new guidance, producers of medical foods will either have to reformulate their products to go through the drug approval process (which can cost billions of dollars) or market them as dietary supplements (which would severely limit the claims their products could make, depriving practitioners and consumers of valuable health information). By making the “buy-in” for the medical industry affordable only to Big Pharma, small businesses and start-up innovators will be kicked out of the industry, drug companies will reap the rewards of yet another FDA-sponsored monopoly, and consumers will be left to deal with the ramifications of limited, more expensive options.

DNA Testing: Do You Have a Right to Test Your Own DNA? FDA Says No! DNA Testing: Do You Have a Right to Test Your Own DNA? FDA Says No!

There’s a reason your government is whittling away at your healthcare options and driving costs out of control—and not a good one. America spends over $2.6 trillion a year (18% of our GDP) on healthcare. At the same time, government is tightening the regulatory reins on nutritional and natural methods to support health—an approach that isn’t lowering healthcare spending, but raising it!

On November 22, the FDA sent a warning letter to 23andMe.com to stop its inexpensive ($99 per test) “do-it-yourself” genetic testing service for health screening and ancestry purposes, because consumers could be “misled” and harm themselves by “self-treating.” The FDA’s stance on DIY genetic testing could very well drive up healthcare costs. Besides premiums being raised on those forced to report DNA results to insurance companies, in-office testing is far more expensive. As tests are priced anywhere from $300 to $3,500, this could significantly add to the overall cost of healthcare.

The FDA’s true message is clear: because individuals can’t be trusted to make sound health decisions, they don’t have a right to private information on their own DNA.

Is Trans Fat “Ban” Paving Way to Promote New Monsanto GMO Product? Is Trans Fat “Ban” Paving Way to Promote New Monsanto GMO Product?

The recent “ban” on trans fats may actually be a way to promote a Monsanto GMO product. It’s important to note that since this is a proposed rule, and not a final one, there’s still a chance it could be changed or dropped. In the rule, the FDA mentions that the agency is open to alternate approaches to addressing partially hydrogenated oils in food, such as the setting of acceptable trans fat threshold levels. The timing and intent of the FDA’s rule is suspect for two reasons. First, it was announced only after most companies had already eliminated trans fat—it’s currently only in a handful of foods. Second, the ban will promote market demand for two new GMO soybeans by Monsanto and DuPont, which are engineered for trans fat free oils.

FDA Sued, Forced to Remove Safety Status on Trans Fats FDA Sued, Forced to Remove Safety Status on Trans Fats

For over 60 years, saturated fats have been wrongfully accused of causing heart disease, despite mounting evidence showing that saturated fat is actually critical for optimal health while trans fat is the dietary fat causing heart disease. The US Food and Drug Administration (FDA) has announced it is now considering removing partially hydrogenated oils—the primary source of trans fats—from the list of “generally recognized as safe” (GRAS) ingredients. Making trans fat non-GRAS is the first step toward getting trans fats out of the American diet altogether. The FDA’s decision comes right on the heels of a lawsuit filed against the agency by a heart disease researcher. FDA is still holding fast to its ignorant view on saturated fats, urging you to “choose products that have the lowest combined amount of saturated fat, cholesterol and trans fat.” This advice causes far more harm than good. Saturated fats from animal and vegetable sources provide a number of important health benefits, and your body requires them for the proper function. Science has firmly debunked the myth that saturated fat promotes heart disease.

FDA Bans Natural Pain Treatment to Protect Patented Drug that does Same Thing FDA Bans Natural Pain Treatment to Protect Patented Drug that does Same Thing

Some 92% of back pain sufferers were relieved by this natural treatment, and gout sufferers too, but now it’s banned to make way for an expensive new copycat FDA approved drug. Colchicine, the active compound in the herb Colchium autumnale, is a powerful healer. It should only be used with qualified professional supervision, but can be very effective. Now this powerfully effective natural medicine is gone, thanks to the FDA.

Ractopamine: The Meat Additive on Your Plate That’s Banned Almost Everywhere But America Ractopamine: The Meat Additive on Your Plate That’s Banned Almost Everywhere But America

Have you ever heard of ractopamine? Neither have most US food consumers though it is used in 80 percent of US pig and cattle operations. The asthma drug-like growth additive, called a beta-agonist, has enjoyed stealth use in the US food supply for a decade despite being widely banned overseas. Ractopamine is banned in the EU, Russia, China, Taiwan and many other countries.

The Center for Food Safety (CFS) and Animal Legal Defense Fund (ALDF) have sued the FDA for withholding records pertaining to ractopamine’s safety.

FDA Approves Rheumatoid Arthritis Drug Banned in Europe and Linked to Deaths FDA Approves Rheumatoid Arthritis Drug Banned in Europe and Linked to Deaths

Rheumatoid arthritis is a painful condition. But killer meds are not the answer. A new class of anti-inflammatory drugs called TNF-alpha blockers are very dangerous. The best-known drugs in this class are Enbrel and Humira, which are used to treat juvenile rheumatoid arthritis, Crohn’s disease, and other inflammatory diseases.

Pfizer’s new anti-inflammatory drug, Xeljanz (tofactinib), caused four patient deaths before it even hit the market. The European regulatory agencies rejected Xeljanz twice on safety grounds, yet the FDA has moved forward and approved it.

Dangerous Anti-Supplement Bill Would Give FDA Power Over Supplements Dangerous Anti-Supplement Bill Would Give FDA Power Over Supplements

The FDA can count on mainstream media to mislead the public. Sen. Dick Durbin (D-IL)’s bill, S.1424, is meant to “improve the safety of dietary supplements by [requiring] manufacturers of dietary supplements to register dietary supplements with the Food and Drug Administration and to amend labeling requirements with respect to dietary supplements.” Sounds innocuous, doesn’t it? But this is nothing but a smokescreen—a naked power grab for the FDA and an attempt to regulate safe dietary supplements as if they were dangerous FDA-approved prescription drugs.

Drug Companies Pay Money to FDA Which Leads to Prescription Drug Abuse Epidemic Drug Companies Pay Money to FDA Which Leads to Prescription Drug Abuse Epidemic

Drug companies paid up to $25,000 to influence FDA policy—the latest in a decades-long FDA/Big Pharma scandal. Since the 1990s, there’s been an explosion in the use and abuse of highly addictive painkillers such as oxycodone (the main ingredient in OxyContin) and hydrocodone (found in drugs like Vicodin). Given the alarming social, health, and even economic costs of this epidemic of painkiller abuse, there has been considerable pressure from both inside and outside the FDA to improve the regulation of these drugs. A recent “pay-to-play” scheme—exposed by the Washington Post earlier this month—hints at the FDA’s real priorities. The Post reports that companies paid as much as $25,000 to attend meetings with FDA officials to shape policy on how drug manufacturers can prove the “safety and effectiveness” of their painkillers.

Will Big Pharma and FDA Soon Move to Regulate Mother’s Raw Breast Milk? Will Big Pharma and FDA Soon Move to Regulate Mother’s Raw Breast Milk?

Online groups of moms sharing their breast milk with those who cannot breast feed their babies has flourished in recent times. A recent study by a professor of Pediatrics at a hospital concluded that raw fresh breast milk was more dangerous than pasteurized breast milk, even though there is not one single instance of a baby ever getting sick from drinking raw breast milk from such groups. Could the FDA be getting ready to move in and regulate raw breast milk, “protecting” children from these dangerous mothers?



Get the news right in your inbox!